Director, Postgraduate Studies Program “Cosmetology-Preparation and Evaluation of Cosmetic Products”
Studies
1985: BSc in Pharmacy, University of Thessaloniki
1991: Ph.D. in Pharmaceutics/Quality Control of Drugs, University of Thessaloniki
1992: Ph.D. in Pharmaceutics, London University
Positions
2015 – today: Professor in University of Patras, Department of Pharmacy,
2015 – today: Affiliated Investigator in Biomedical Research Foundation, Academy of Athens, Greece,
2008 – 2015: Associate Professor in University of Patras, Department of Pharmacy, Pharmaceutics Lab., Rio 26 500, Patras, Greece
2000 - 2008: Assistant Professor in University of Patras, Department of Pharmacy, Pharmaceutics Lab., Rio 26 500, Patras, Greece
1994-2000: Lecturer in the Department of Pharmacy, University of Patras.
1993-1994 : Research assistant in Institute of Radioisotopes and Radiodiagnostic Products, NCSR "Demokritos", Athens, Greece
Teaching Activity
Undergraduate Program
- Pharmaceutical Technology I [PHA-C22-NEW]
- Pharmaceutical Technology II [PHA-D12-NEW]
- Basic Principles of Nuclear Pharmacy & Radiopharmacy [PHA-E12-NEW]
- Chemistry and Technology of Cosmetics [PHA-E23-NEW]
Postgraduate Program “Drug Design and Development”
- Design and Development of Pharmaceutical Products [DPHA_2]
- Nanomedicines and special systems for administration and/or targeting of drugs/imaging agents [DPHA_B01]
- Statistics and quality management in Pharmacy [DPHA_B02]
Postgraduate Program “Cosmetology-Preparation and Evaluation of Cosmetic Products”
- Ingredients of Cosmetic Products [PHA-COS-13]
- Development of Cosmetic Products [PHA-COS-15]
- Quality and Safety Testing of Cosmetic Products [PHA-COS-21]
- Industrial Production of Cosmetic Products [PHA-COS-24]
- Practical Course on Preparation of Cosmetic Products [PHA-COS-25]
Research Interests
- Targeted delivery of anticancer drugs based on i) biodegradable, polymeric, long-circulating (“stealth”) nanoparticles and ii) magnetic hybrid organic-inorganic nanoparticles,
- Development of novel prophylactic or therapeutic vaccines based on biodegradable and biocompatible, polymeric nano- and micro-particles,
- Development of formulations for the efficient delivery of drugs with limited aqueous solubility
